Download the Free Fishpond App!
Download on the App Store

Android App on Google play
God and Gerson Therapy: Diary of a Cancer Patient

Already own it?

Sell Yours
Home » Books » Health & Wellbeing » General

God and Gerson Therapy

Diary of a Cancer Patient

By Lynn Ford

Elsewhere $37.99 $31.90   Save $6.09 (16%)
Price includes NZ wide delivery!
Ships from USA
Order now for Christmas delivery
Register or sign-in to rate and get recommendations.
Format: Paperback, 208 pages
Published In: United States, 21 March 2014
Lynn Ford was a vibrant, healthy Christian woman, until her Dr. told her she had bladder cancer just days after her 51st birthday. "God and Gerson Therapy: Diary of a Cancer Patient," is a real time account of the emotional panic, the confusion and an array of mental and physical challenges Lynn faces and struggles through, with God, as she seeks alternatives to empty choices offered by traditional medicine. She takes us through her discovery of Gerson therapy, embracing the controversial methodology and almost unbelievable promises of remission and health. As if sitting with us at her kitchen table, she delivers thoughts on character, courage, faith, health and the power of loving relationships. This short adventure is a great compliment to other Gerson Therapy books.
EAN: 9781495257308
ISBN: 1495257304
Publisher: Createspace
Dimensions: 22.86 x 15.24 x 1.12 centimetres (0.37 kg)
Age Range: 15+ years
Tell a friend

Their Email:

Sell Yours

Already own this item?
Sell Yours and earn some cash. It's fast and free to list! (Learn More.)

Review this Product


Related Searches


Webmasters, Bloggers & Website Owners

You can earn a 5% commission by selling God and Gerson Therapy: Diary of a Cancer Patient on your website. It's easy to get started - we will give you example code. After you're set-up, your website can earn you money while you work, play or even sleep!



Are you the Author/Publisher? Improve sales by submitting additional information on this title.


This item ships from and is sold by, Inc.